Join to View Full Profile
Thrive Home Health LLC17530 NE Union Hill Ste 140Redmond, WA 98052
Phone+1 425-553-4325
Fax+1 425-249-3189
Dr. Han is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York-Presbyterian/QueensInternship, Internal Medicine, 2015 - 2018
China Medical University ShenyangClass of 2008
Certifications & Licensure
CA State Medical License 2019 - 2025
WA State Medical License 2018 - 2025
NY State Medical License 2018 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer Start of enrollment: 2018 Mar 01
- XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer Start of enrollment: 2018 Mar 01
Publications & Presentations
PubMed
- 10 citationsDownregulation of G protein-coupled receptor kinase 4 protects against kidney ischemia-reperfusion injury.Donghai Yang, Ming Tang, Mingming Zhang, Hongmei Ren, Xiaoping Li
Kidney International. 2023-04-01 - 18 citationsMembrane-delimited signaling and cytosolic action of MG53 preserve hepatocyte integrity during drug-induced liver injury.Yu Han, Sylvester M. Black, Zhengfan Gong, Zhi Chen, Jae-Kyun Ko
Journal of Hepatology. 2021-11-01 - 17 citationsCalorie Restriction Protects against Contrast-Induced Nephropathy via SIRT1/GPX4 Activation.Dandong Fang, Yongbin Wang, Ziyue Zhang, Donghai Yang, Daqian Gu
Oxidative Medicine and Cellular Longevity. 2021-10-19
Press Mentions
Elucidating the Immune Infiltration in Acne and Its Comparison with Rosacea by Integrated Bioinformatics AnalysisMarch 24th, 2021- Comparisons of Retinal Vessel Density and Glaucomatous Parameters in Optical Coherence Tomography AngiographyJune 25th, 2020
Identification of Hub Genes and Therapeutic Drugs in Esophageal Squamous Cell Carcinoma Based on Integrated Bioinformatics StrategyMay 22nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
